Douglas W. Losordo - Jan 19, 2023 Form 3/A - Amendment Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Medical Officer
Signature
/s/ Douglas Losordo
Stock symbol
CVKD
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/31/2023, 06:16 AM
Date Of Original Report
Jan 19, 2023
Previous filing
Dec 22, 2022
Next filing
Dec 26, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVKD Stock Options Jan 19, 2023 Common Stock 300K $0.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Amendment is being filed to correct the vesting commencement date and provide the vesting schedule for the stock option grant.
F2 The options to purchase shares of common stock, par value $0.001 per share, of Cadrenal Therapeutics, Inc., which options vest and become exercisable 1/12th on October 1, 2022 and the balance vests 1/12th every three (3) months thereafter, subject to the reporting person's continued service to the Company.

Remarks:

This Amendment is being filed to correct the vesting commencement date and provide the vesting schedule for the stock option grant.